Healthcare

By

Bruce Kamich

 | Apr 3, 2017 | 9:21 AM EDT
Support is likely to develop in the $38-$34 area.
By

Jim Cramer

 | Mar 31, 2017 | 6:04 AM EDT
Buyers of classic senior growth stocks have returned to their old flames.
By

Bruce Kamich

 | Mar 29, 2017 | 3:00 PM EDT
Technical indicators suggest GSK can see further significant gains in 2017.
By

Bret Jensen

 | Mar 27, 2017 | 11:38 AM EDT
The failure of ACA repeal isn't the only troublesome sign for the markets.
By

Jim Cramer

 | Mar 27, 2017 | 6:25 AM EDT
Particularly if Trump lets the sleeping (health-care) dog lie and gets back to deregulation and tax reform.
By

Bret Jensen

 | Mar 26, 2017 | 2:00 PM EDT
Answering questions from the Biotech Mailbag on FLXN and SGYP.
By

James "Rev Shark" DePorre

 | Mar 24, 2017 | 4:19 PM EDT
Failure of health-care bill barely causes a ripple.
By

Bret Jensen

 | Mar 24, 2017 | 11:30 AM EDT
Answering questions from the Biotech Mailbag on FLXN and SGYP.
By

James "Rev Shark" DePorre

 | Mar 24, 2017 | 7:14 AM EDT
The health care debate isn't about health care. It is about leadership and deal making.
By

Jim Cramer

 | Mar 23, 2017 | 12:32 PM EDT
If it passes, interest rates and stocks should go higher.

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.